SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)

• Principais autores: Sahil Khanna (Autor), Matthew Sims (Autor), Thomas J. Louie (Autor), Monika Fischer (Autor), Kerry LaPlante (Autor), Jessica Allegretti (Autor), Brooke R. Hasson (Autor), Allyson T. Fonte (Autor), Christopher McChalicher (Autor), David S. Ege (Autor), Jessica A. Bryant (Autor), Timothy J. Straub (Autor), Christopher B. Ford (Autor), Matthew R. Henn (Autor), Elaine E. L. Wang (Autor), Lisa von Moltke (Autor), Mark H. Wilcox (Autor)
• Formato: Livro
• Publicado em: MDPI AG, 2022-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

<i>Clostridioides</i> <i>difficile</i> infection (CDI) is classified as an urgent health threat by the Centers for Disease Control and Prevention (CDC), and affects nearly 500,000 Americans annually. Approximately 20-25% of patients with a primary infection experience a recur...